{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T03:49:13Z","timestamp":1793677753779,"version":"4.5.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-03145-x","type":"journal-article","created":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T16:43:42Z","timestamp":1756745022000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Barriers and strategies to enhance HPV vaccine uptake in adolescents living with HIV and their guardians in Lilongwe, Malawi"],"prefix":"10.1038","volume":"15","author":[{"given":"Chikondi","family":"Masamba Makanani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alinane Linda","family":"Nyondo-Mipando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Jumbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,1]]},"reference":[{"issue":"5","key":"3145_CR1","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1080\/01443615.2019.1634030","volume":"40","author":"KS Okunade","year":"2020","unstructured":"Okunade, K. S. Human papillomavirus and cervical cancer. J. Obstet. Gynaecol. (Lahore). 40 (5), 602\u2013608 (2020).","journal-title":"J. Obstet. Gynaecol. (Lahore)"},{"issue":"4","key":"3145_CR2","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1002\/ijc.30716","volume":"141","author":"C de Martel","year":"2017","unstructured":"de Martel, C., Plummer, M., Vignat, J. & Franceschi, S. Worldwide burden of cancer attributable to HPV by site, country and HPV type. Int. J. Cancer. 141 (4), 664\u2013670 (2017).","journal-title":"Int. J. Cancer"},{"issue":"3","key":"3145_CR3","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global Cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71 (3), 209\u2013249 (2021).","journal-title":"CA Cancer J. Clin."},{"key":"3145_CR4","unstructured":"WHO. A cervical cancer-free future: First-ever global commitment to eliminate a cancer.   https:\/\/www.who.int\/news\/item\/17-11-2020-a-cervica  (2020)."},{"key":"3145_CR5","unstructured":"Bruni, L. et al. Human papillomavirus and related diseases report in world. ICO\/IARC Inf. Cent. HPV Cancer (HPV Inf. Centre) 1\u2013303.  (2021)."},{"key":"3145_CR6","doi-asserted-by":"publisher","unstructured":"Canfell, K. Towards the global elimination of cervical cancer. Papillomavirus Res. 8 100170.   https:\/\/doi.org\/10.1016\/j.pvr.2019.100170  (2019).","DOI":"10.1016\/j.pvr.2019.100170"},{"issue":"Suppl 4","key":"3145_CR7","doi-asserted-by":"publisher","first-page":"S367","DOI":"10.1093\/infdis\/jiaa621","volume":"224","author":"LE Markowitz","year":"2021","unstructured":"Markowitz, L. E. & Schiller, J. T. Human papillomavirus vaccines. J. Infect. Dis. 224 (Suppl 4), S367\u2013S378 (2021).","journal-title":"J. Infect. Dis."},{"key":"3145_CR8","unstructured":"World Health Organization. GVAP 2011\u20132020, Review and Lessons Learned;Strategic Advisory Group of Experts on Immunization. 1\u201344. https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/329097\/WHO-IVB-19.07-eng.pdf?ua=1 (2020)."},{"key":"3145_CR9","unstructured":"Government of Malawi. National cancer Control Strategic Plan (Government of Malawi, 2019)."},{"key":"3145_CR10","unstructured":"Magombo, K. Malawi launches HPV vaccine campaign: Minister Muluzi says cervical cancer leading cause of women\u2019s deaths -. Malawi Nyasa Times 4\u20137.  https:\/\/www.nyasatimes.com\/malawi-launches-hpv-vaccine-campaign-minister-muluzi-says-cervical-cancer-leading-cause-of-womens-deaths\/  (2019)."},{"issue":"1","key":"3145_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12889-017-4526-y","volume":"17","author":"KP Msyamboza","year":"2017","unstructured":"Msyamboza, K. P., Mwagomba, B. M., Valle, M., Chiumia, H. & Phiri, T. Implementation of a human papillomavirus vaccination demonstration project in Malawi: successes and challenges. BMC Public. Health. 17 (1), 1\u20137 (2017).","journal-title":"BMC Public. Health"},{"key":"3145_CR12","unstructured":"World Health Organisation. Guide To Introducing HPV Vaccine into National Imminization Programmes (World Health Organization, 2016)."},{"key":"3145_CR13","unstructured":"Government of Malawi. National cervical cancer control Strategy 2016\u20132020.  Government of Malawi. Lilongwe: Government of Malawi.  (2017)."},{"key":"3145_CR14","doi-asserted-by":"crossref","unstructured":"P\u00e9rez-Gonz\u00e1lez, A., Cachay, E., Ocampo, A. & Poveda, E. Update on the epidemiological features and clinical implications of human papillomavirus infection (HPV) and human immunodeficiency virus (HIV) coinfection. Microorganisms  10 (5). (2022).","DOI":"10.3390\/microorganisms10051047"},{"issue":"10","key":"3145_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/vaccines11101614","volume":"11","author":"D Yuan","year":"2023","unstructured":"Yuan, D. et al. HPV infection profiles among people living with HIV and HPV vaccine acceptance among individuals with different HIV infection statuses in China: A systematic Meta-Analysis. Vaccines 11 (10), 1\u201320 (2023).","journal-title":"Vaccines"},{"key":"3145_CR16","doi-asserted-by":"publisher","unstructured":"Tian, T. et al. HPV vaccination acceptability among men who have sex with men in Urumqi, China. Hum. Vaccines Immunother. 15 (4), 1005\u201312.  https:\/\/doi.org\/10.1080\/21645515.2018.1520591 (2019).","DOI":"10.1080\/21645515.2018.1520591"},{"key":"3145_CR17","doi-asserted-by":"publisher","unstructured":"van der Schim, M. F., Vorsters, A., Marra, E., Van Damme, P. & Hogewoning, A. Should female sex workers be offered HPV vaccination? Hum. Vaccines Immunother.  15 (7\u20138), 1544\u20138. https:\/\/doi.org\/10.1080\/21645515.2019.1602432 (2019).","DOI":"10.1080\/21645515.2019.1602432"},{"issue":"4","key":"3145_CR18","first-page":"351","volume":"15","author":"KR Mcleroy","year":"1988","unstructured":"Mcleroy, K. R., Bibeau, D., Steckler, A. & Glanz, K. An ecological perspective on health promotion programs. Heal Educ. Behav. 15 (4), 351\u2013377 (1988).","journal-title":"Heal Educ. Behav."},{"key":"3145_CR19","doi-asserted-by":"crossref","unstructured":"Watson-Jones, D. et al. Reasons for receiving or not receiving HPV vaccination in primary schoolgirls in Tanzania: A case control study. PLoS ONE  7 (10). (2012).","DOI":"10.1371\/journal.pone.0045231"},{"key":"3145_CR20","doi-asserted-by":"crossref","unstructured":"Qutoshi, S. B. Journal of education and educational developement discussion phenomenology: A philosophy and method of inquiry.  5 (1), 215\u201322. (2018).","DOI":"10.22555\/joeed.v5i1.2154"},{"issue":"1","key":"3145_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/1609406917733847","volume":"16","author":"LS Nowell","year":"2017","unstructured":"Nowell, L. S., Norris, J. M., White, D. E. & Moules, N. J. Thematic analysis: striving to Meet the trustworthiness criteria. Int. J. Qual. Methods. 16 (1), 1\u201313 (2017).","journal-title":"Int. J. Qual. Methods"},{"issue":"August","key":"3145_CR22","first-page":"1","volume":"8","author":"A Ciavattini","year":"2021","unstructured":"Ciavattini, A. et al. The impact of 9-Valent HPV vaccination on couple infertility prevention: A comprehensive review. Front. Med. 8 (August), 1\u201313 (2021).","journal-title":"Front. Med."},{"issue":"8","key":"3145_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1001\/jamanetworkopen.2021.20391","volume":"4","author":"A Hviid","year":"2021","unstructured":"Hviid, A. & Myrup Thiesson, E. Association between human papillomavirus vaccination and primary ovarian insufficiency in a nationwide cohort. JAMA Netw. Open 4 (8), 1\u201310 (2021).","journal-title":"JAMA Netw. Open."},{"key":"3145_CR24","doi-asserted-by":"publisher","unstructured":"Qaderi, K., Mirmolaei, S. T., Geranmayeh, M., Farnam, F. & Sheikh Hasani, S. Does HPV affect my fertility? Reproductive concerns of HPV-positive women: a qualitative study. Reprod. Health  18 (1), 1\u201311.  https:\/\/doi.org\/10.1186\/s12978-021-01126-7 (2021).","DOI":"10.1186\/s12978-021-01126-7"},{"key":"3145_CR25","doi-asserted-by":"publisher","unstructured":"Moucheraud, C. et al. Malawian caregivers\u2019 experiences with HPV vaccination for preadolescent girls: A qualitative study. Vaccine X 14 100315. https:\/\/doi.org\/10.1016\/j.jvacx.2023.100315  (2023).","DOI":"10.1016\/j.jvacx.2023.100315"},{"key":"3145_CR26","doi-asserted-by":"publisher","unstructured":"Wilson, R. J., Leigh, L., Bah, H., Larson, H. J. & Clarke, E. HPV vaccination acceptance and perceptions related to fertility and population control in the Gambia: An anthropological analysis. Vaccine  https:\/\/doi.org\/10.1016\/j.vaccine.2023.04.072 (2023).","DOI":"10.1016\/j.vaccine.2023.04.072"},{"key":"3145_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7554\/eLife.85743","volume":"12","author":"EK Vraga","year":"2023","unstructured":"Vraga, E. K. et al. A review of HPV and HBV vaccine hesitancy, intention, and uptake in the era of social media and COVID-19. Elife 12, 1\u201310 (2023).","journal-title":"Elife"},{"key":"3145_CR28","doi-asserted-by":"crossref","unstructured":"Neto, N., Ramos, V. & Kielmann, K. Health literacy in African countries: a scoping review.  1\u201320. (2023).","DOI":"10.21203\/rs.3.rs-3156619\/v1"},{"issue":"24","key":"3145_CR29","doi-asserted-by":"publisher","first-page":"4038","DOI":"10.1016\/j.vaccine.2020.03.035","volume":"38","author":"NB Schmuhl","year":"2020","unstructured":"Schmuhl, N. B. et al. No association between HPV vaccination and infertility in U.S. Females 18\u201333 years old. Vaccine 38 (24), 4038\u20134043. https:\/\/doi.org\/10.1016\/j.vaccine.2020.03.035 (2020).","journal-title":"Vaccine"},{"issue":"November","key":"3145_CR30","first-page":"1","volume":"3","author":"I Hajj Hussein","year":"2015","unstructured":"Hajj Hussein, I. et al. Vaccines through centuries: major cornerstones of global health. Front. Public. Heal. 3 (November), 1\u201316 (2015).","journal-title":"Front. Public. Heal"},{"key":"3145_CR31","doi-asserted-by":"crossref","unstructured":"Fokom Domgue J, Dille I, Kapambwe S, Yu R, Gnangnon F, Chinula L, et al. HPV vaccination in Africa in the COVID-19 era: a cross-sectional survey of healthcare providers\u2019knowledge, training, and recommendation practices. Front. Public Heal. 12 (2024).","DOI":"10.3389\/fpubh.2024.1343064"},{"issue":"1","key":"3145_CR32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5334\/aogh.2526","volume":"86","author":"NY Nguyen","year":"2020","unstructured":"Nguyen, N. Y., Okeke, E., Anglemyer, A. & Brock, T. Identifying perceived barriers to human papillomavirus vaccination as a preventative strategy for cervical cancer in Nigeria. Ann. Glob Heal. 86 (1), 1\u20138 (2020).","journal-title":"Ann. Glob Heal"},{"issue":"December 2019","key":"3145_CR33","first-page":"2019","volume":"9","author":"SM Garland","year":"2020","unstructured":"Garland, S. M. et al. IPVS statement on temporary HPV vaccine shortage: implications globally to achieve equity. Papillomavirus Res. 9 (December 2019), 2019\u20132021 (2020).","journal-title":"Papillomavirus Res."},{"key":"3145_CR34","doi-asserted-by":"publisher","unstructured":"McKenzie, A. H. et al. Parents\u2019 stigmatizing beliefs about the HPV vaccine and their association with information seeking behavior and vaccination communication behaviors. Hum. Vaccines Immunother. 19 (1), 1\u20139.    https:\/\/doi.org\/10.1080\/21645515.2023.2214054 (2023).","DOI":"10.1080\/21645515.2023.2214054"},{"key":"3145_CR35","doi-asserted-by":"crossref","unstructured":"Njuguna, D. W., Mahrouseh, N., Isowamwen, O. V. & Varga, O. Knowledge, attitude and practice of main stakeholders towards human papilloma virus infection and vaccination in Mombasa and tana-river counties in Kenya: A qualitative study. Vaccines  9 (10). (2021).","DOI":"10.3390\/vaccines9101099"},{"issue":"1","key":"3145_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12889-023-15182-0","volume":"23","author":"I Song","year":"2023","unstructured":"Song, I. & Lee, S. H. COVID-19 vaccine refusal associated with health literacy: findings from a population-based survey in Korea. BMC Public. Health  23 (1), 1\u20138 (2023).","journal-title":"BMC Public. Health"},{"key":"3145_CR37","doi-asserted-by":"publisher","unstructured":"Wu, J. et al. How urban versus rural residency relates to COVID-19 vaccine hesitancy: A large-scale national Chinese study. Soc. Sci. Med. 320 115695.  https:\/\/doi.org\/10.1016\/j.socscimed.2023.115695 (2023).","DOI":"10.1016\/j.socscimed.2023.115695"},{"issue":"4","key":"3145_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/healthcare5040086","volume":"5","author":"O Nwanodi","year":"2017","unstructured":"Nwanodi, O., Salisbury, H. & Bay, C. Multimodal counseling interventions: effect on human papilloma virus vaccination acceptance. Healthc 5 (4), 1\u201318 (2017).","journal-title":"Healthc"},{"issue":"2","key":"3145_CR39","first-page":"139","volume":"33","author":"Christy Widman Elisa Marie Rodriguez Frances G Saad","year":"2017","unstructured":"Christy Widman Elisa Marie Rodriguez Frances G Saad-. Harfouche1 Anne F Pierce Morgan T Annamaria Masucci Twarozek P. Clinician and parent perspectives on educational needs for increasing adolescent HPV vaccination. J. Cancer Educ. 33 (2), 139\u2013148 (2017).","journal-title":"J. Cancer Educ."},{"key":"3145_CR40","doi-asserted-by":"publisher","unstructured":"Lake, P. et al. HPV vaccine recommendations by age: A survey of providers in federally qualified health centers ABSTRACT. Hum. Vac. Immunother. 19 (1), 1\u20139.  https:\/\/doi.org\/10.1080\/21645515.2023.2181610 (2023).","DOI":"10.1080\/21645515.2023.2181610"},{"key":"3145_CR41","doi-asserted-by":"publisher","unstructured":"Gilkey, M. B. et al. Provider communication and HPV vaccination: The impact of recommendation quality. Vaccine  34 (9), 1187\u201392.   https:\/\/doi.org\/10.1016\/j.vaccine.2016.01.023 (2020).","DOI":"10.1016\/j.vaccine.2016.01.023"},{"key":"3145_CR42","doi-asserted-by":"crossref","unstructured":"Osaghae, I., Chido-amajuoyi, O. G. & Shete, S. Healthcare provider recommendations and observed changes in HPV vaccination acceptance during the COVID-19 pandemic.  4\u201311. (2022).","DOI":"10.3390\/vaccines10091515"},{"issue":"3","key":"3145_CR43","first-page":"139","volume":"176","author":"P Katie","year":"2016","unstructured":"Katie, P., Diane, M. & Reddy Barriers and facilitators to HPV vaccination: perspectives from Malawian women. Women Heal. 176 (3), 139\u2013148 (2016).","journal-title":"Women Heal"},{"issue":"1","key":"3145_CR44","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/ijgo.13482","volume":"152","author":"S Kumar","year":"2021","unstructured":"Kumar, S. et al. Acting on the call: A framework for action for rapid acceleration of access to the HPV vaccination in low- and lower-middle-income countries. Int. J. Gynecol. Obstet. 152 (1), 32\u201339 (2021).","journal-title":"Int. J. Gynecol. Obstet."},{"issue":"Suppl 1","key":"3145_CR45","doi-asserted-by":"publisher","first-page":"A26","DOI":"10.1016\/j.vaccine.2021.01.036","volume":"40","author":"AJ Li","year":"2022","unstructured":"Li, A. J. et al. Impact of the human papillomavirus (HPV) vaccine supply shortage on Tanzania\u2019s National HPV vaccine introduction. Vaccine 40 (Suppl 1), A26\u2013A29 (2022).","journal-title":"Vaccine"},{"key":"3145_CR46","doi-asserted-by":"crossref","unstructured":"Fleszar-Pavlovi\u0107, S. E. & Cameron, L. D. Developing a narrative communication intervention in the context of HPV vaccination. PEC Innov.  4 (2024).","DOI":"10.1016\/j.pecinn.2024.100272"},{"issue":"2","key":"3145_CR47","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.vaccine.2017.11.038","volume":"36","author":"K Bonner","year":"2018","unstructured":"Bonner, K., Banura, C. & Basta, N. E. HPV vaccination strategies targeting hard-to-reach populations: Out-of-school girls in LMICs. Vaccine 36 (2), 191\u2013193 (2018).","journal-title":"Vaccine"},{"key":"3145_CR48","doi-asserted-by":"publisher","unstructured":"Tsu, V. D., LaMontagne, D. S., Atuhebwe, P., Bloem, P. N. & Ndiaye, C. National implementation of HPV vaccination programs in low-resource countries: Lessons, challenges, and future prospects. Prev. Med. (Baltimore) 2021 144.   https:\/\/doi.org\/10.1016\/j.ypmed.2020.106335 (2020).","DOI":"10.1016\/j.ypmed.2020.106335"},{"key":"3145_CR49","doi-asserted-by":"crossref","unstructured":"Waheed, D. E. N. et al. Planning, implementation, and sustaining high coverage of human papillomavirus (HPV) vaccination programs: what works in the context of low-resource countries? Front. Public. Heal.  11  (2023).","DOI":"10.3389\/fpubh.2023.1112981"},{"issue":"5","key":"3145_CR50","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1111\/phn.12070","volume":"30","author":"K Lisy","year":"2013","unstructured":"Lisy, K. Integration of HIV\/AIDS services with maternal, neonatal and child health, nutrition, and family planning services. Public. Health Nurs. 30 (5), 451\u2013453 (2013).","journal-title":"Public. Health Nurs."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-03145-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-03145-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-03145-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T03:40:29Z","timestamp":1757475629000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-03145-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,1]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3145"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-03145-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5629404\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,1]]},"assertion":[{"value":"12 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was approved by the College of Medicine Research and Ethics Committee (COMREC P.11\/21\/3451). Permission was granted by the Lilongwe District Health Office. Informed Consent was obtained from all the participants. All minors involved in the study had their parents or guardians provide parental consent. In addition, written assent was obtained from each minor. All participants were assured of their privacy, confidentiality, and anonymity, and discussions were conducted in private settings to provide a safe environment for participants to share their experiences without fear of disclosure.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical clearance"}}],"article-number":"32230"}}